4.7 Letter

Description of plasmid pSM52, harbouring the gene for the Smr efflux pump, and its involvement in resistance to biocides in a meticillin-resistant Staphylococcus aureus strain

Journal

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Volume 41, Issue 5, Pages 490-492

Publisher

ELSEVIER
DOI: 10.1016/j.ijantimicag.2013.01.003

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Respiratory System

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment

Sophia B. Georghiou, Timothy C. Rodwell, Alexei Korobitsyn, Said H. Abbadi, Kanchan Ajbani, Jan-Willem Alffenaar, David Alland, Nataly Alvarez, Sonke Andres, Elisa Ardizzoni, Alexandra Aubry, Rossella Baldan, Marie Ballif, Ivan Barilar, Erik C. Bottger, Soumitesh Chakravorty, Pauline M. Claxton, Daniela M. Cirillo, Inaki Comas, Chris Coulter, Claudia M. Denkinger, Brigitta Derendinger, Edward P. Desmond, Jurriaan E. M. de Steenwinkel, Keertan Dheda, Andreas H. Diacon, David L. Dolinger, Kelly E. Dooley, Matthias Egger, Maha R. Farhat, Lanfranco Fattorini, Iris Finci, Laure Fournier Le Ray, Victoria Furio, Ramona Groenheit, Tawanda Gumbo, Scott K. Heysell, Doris Hillemann, Harald Hoffmann, Po-Ren Hsueh, Yi Hu, Hairong Huang, Alamdar Hussain, Farzana Ismail, Kiyohiko Izumi, Tomasz Jagielski, John L. Johnson, Priti Kambli, Kone Kaniga, G. H. R. Eranga Karunaratne, Meenu Kaushal Sharma, Peter M. Keller, Ellis C. Kelly, Margarita Kholina, Mikashmi Kohli, Katharina Kranzer, Ian F. Laurenson, Jason Limberis, S-Y Grace Lin, Yongge Liu, Alexandre Lopez-Gavin, Anna Lyander, Diana Machado, Elena Martinez, Faisal Masood, Satoshi Mitarai, Nomonde R. Mvelase, Stefan Niemann, Vladyslav Nikolayevskyy, Florian P. Maurer, Matthias Merker, Paolo Miotto, Shaheed Omar, Ralf Otto-Knapp, Moises Palaci, Juan Jose Palacios Gutierrez, Sharon J. Peacock, Charles A. Peloquin, Jennifer Perera, Catherine Pierre-Audigier, Suporn Pholwat, James E. Posey, Therdsak Prammananan, Leen Rigouts, Jaime Robledo, Neesha Rockwood, Camilla Rodrigues, Max Salfinger, Marcos C. Schechter, Marva Seifert, Sarah Sengstake, Thomas Shinnick, Natalia Shubladze, Vitali Sintchenko, Frederick Sirgel, Sulochana Somasundaram, Timothy R. Sterling, Andrea Spitaleri, Elizabeth Streicher, Philip Supply, Erik Svensson, Elisa Tagliani, Sabira Tahseen, Akiko Takaki, Grant Theron, Gabriela Torrea, Armand Van Deun, Annelies Van Rie, Dick van Soolingen, Roger Vargas, Amour Venter, Nicolas Veziris, Cristina Villellas, Miguel Viveiros, Robin Warren, Shu'an Wen, Jim Werngren, Robert J. Wilkinson, Caie Yang, Tingting Zhang, Danila Zimenkov, Nazir Ismail, Thomas Schon, Claudio U. Koser, Soudeh Ehsani, Jakko van Ingen, F. Ferda Yilmaz

EUROPEAN RESPIRATORY JOURNAL (2022)

Editorial Material Infectious Diseases

Rapid molecular diagnostics to detect resistance to second-line anti-TB drugs

A. L. Kritski, M. Viveiros, A. C. C. C. Arvalho

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2022)

Article Infectious Diseases

Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid

Anna Bateson, Julio Ortiz Canseco, Timothy D. McHugh, Adam A. Witney, Silke Feuerriegel, Matthias Merker, Thomas A. Kohl, Christian Utpatel, Stefan Niemann, Sonke Andres, Katharina Kranzer, Florian P. Maurer, Arash Ghodousi, Emanuele Borroni, Daniela Maria Cirillo, Maria Wijkander, Juan C. Toro, Ramona Groenheit, Jim Werngren, Diana Machado, Miguel Viveiros, Robin M. Warren, Frederick Sirgel, Anzaan Dippenaar, Claudio U. Koeser, Eugene Sun, Juliano Timm

Summary: The study reveals ancient differences in susceptibility to pretomanid among different lineages of Mycobacterium tuberculosis complex (MTBC) and recent emergence of resistance. The findings highlight the significance of considering global diversity of MTBC in clinical drug development and defining breakpoints for antimicrobial susceptibility testing.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

Review Biochemistry & Molecular Biology

Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates

Liliana Rodrigues, Renata Bento Cunha, Tatiana Vassilevskaia, Miguel Viveiros, Celso Cunha

Summary: This article provides an overview of the main developments in COVID-19 treatment and the contribution of drug repurposing. It also introduces a new drug repurposing strategy and lists 11 compounds that may be effective against COVID-19.

MOLECULES (2022)

Article Pharmacology & Pharmacy

In vitro Evaluation of Isoniazid Derivatives as Potential Agents Against Drug-Resistant Tuberculosis

Joaquim Trigo Marques, Catarina Frazao De Faria, Marina Reis, Diana Machado, Susana Santos, Maria da Soledade Santos, Miguel Viveiros, Filomena Martins, Rodrigo F. M. De Almeida

Summary: The increase in multidrug-resistant tuberculosis has made the challenge of ending this epidemic by 2030 even tougher. This has led to a search for more efficient antitubercular compounds, with a focus on isoniazid derivatives in this study. The study evaluates the cytotoxicity, binding to human serum albumin, and activity against resistant strains of Mycobacterium tuberculosis of these derivatives, showing promising results for their potential use as improved treatments.

FRONTIERS IN PHARMACOLOGY (2022)

Article Infectious Diseases

Staphylococcus aureus Causing Skin and Soft Tissue Infections in Companion Animals: Antimicrobial Resistance Profiles and Clonal Lineages

Sofia Santos Costa, Rute Ribeiro, Maria Serrano, Ketlyn Oliveira, Carolina Ferreira, Marta Leal, Constanca Pomba, Isabel Couto

Summary: This study investigated Staphylococcus aureus as a cause of skin and soft tissue infections in animals. It found a high frequency of MRSA strains and highlighted the circulation of clonal lineages between companion animals and humans.

ANTIBIOTICS-BASEL (2022)

Article Multidisciplinary Sciences

Genomic epidemiological analysis of Klebsiella pneumoniae from Portuguese hospitals reveals insights into circulating antimicrobial resistance

Anton Spadar, Jody Phelan, Rita Elias, Ana Modesto, Catia Caneiras, Catia Marques, Luis Lito, Margarida Pinto, Patricia Cavaco-Silva, Helena Ferreira, Constanca Pomba, Gabriela J. Da Silva, Maria Jose Saavedra, Jose Melo-Cristino, Aida Duarte, Susana Campino, Joao Perdigao, Taane G. Clark

Summary: Kp bacteria in Portugal exhibit widespread antimicrobial resistance, with predominant sequence types of ST15, ST147, ST14, and ST13. The most common carbapenemase gene is bla(KPC-3). The plasmid group associated with bla(CTX-M-15) appears to have been replaced by another group carrying bla(KPC-3) gene.

SCIENTIFIC REPORTS (2022)

Article Microbiology

Continued Vaccine Breakthrough Cases of Serotype 3 Complicated Pneumonia in Vaccinated Children, Portugal (2016-2019)

Catarina Silva-Costa, Joana Gomes-Silva, Marcos D. Pinho, Ana Friaes, Mario Ramirez, Jose Melo-Cristino

Summary: Despite the use of pneumococcal conjugate vaccines (PCVs), vaccine serotypes still remain important causes of pneumonia with pleural effusion and empyema. Serotype 3 is the most frequent serotype associated with vaccine breakthrough cases. Molecular diagnostics play a crucial role in identifying and serotyping Streptococcus pneumoniae.

MICROBIOLOGY SPECTRUM (2022)

Article Infectious Diseases

In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies)

Marta Hernandez-Garcia, Maria Garcia-Castillo, Jose Melo-Cristino, Margarida F. Pinto, Elsa Goncalves, Valquiria Alves, Ana Raquel Vieira, Elmano Ramalheira, Luisa Sancho, Jose Diogo, Rui Ferreira, Hugo Cruz, Catarina Chaves, German Bou, Emilia Cercenado, Mercedes Delgado-Valverde, Antonio Oliver, Cristina Pitart, Jesus Rodriguez-Lozano, Nuria Tormo, Jazmin Diaz-Reganon, Leonor Passaro, Joana Duarte, Rafael Canton

Summary: This study analyzed the in vitro activity and resistance mechanisms of imipenem/relebactam in Pseudomonas aeruginosa isolates from Portugal and Spain. The results showed that imipenem/relebactam displayed comparable activity to other comparators and had a relatively low resistance rate. Different genetic structures and carbapenemase gene distributions were found in isolates from the two countries.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)

Article Microbiology

Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies)

Marta Hernandez-Garcia, Maria Garcia-Castillo, German Bou, Emilia Cercenado, Mercedes Delgado-Valverde, Antonio Oliver, Cristina Pitart, Jesus Rodriguez-Lozano, Nuria Tormo, Jose Melo-Cristino, Margarida F. Pinto, Elsa Goncalves, Valquiria Alves, Ana Raquel Vieira, Elmano Ramalheira, Luisa Sancho, Jose Diogo, Rui Ferreira, Hugo Cruz, Catarina Chaves, Joana Duarte, Leonor Passaro, Jazmin Diaz-Reganon, Rafael Canton

Summary: This study evaluated the in vitro activity of imipenem-relebactam and comparators against Enterobacterales clinical isolates and found that imipenem-relebactam showed excellent activity against extended-spectrum beta-lactamase and carbapenemase-producing isolates, with low resistance rates in multidrug-resistant strains.

MICROBIOLOGY SPECTRUM (2022)

Article Biochemistry & Molecular Biology

Occurrence and Variability of the Efflux Pump Gene norA across the Staphylococcus Genus

Carolina Ferreira, Patricia Abrantes, Sofia Santos Costa, Miguel Viveiros, Isabel Couto

Summary: This study identified the variability of norA within Staphylococcus aureus and its distribution among other staphylococci. It also demonstrated the applicability of a PCR-based algorithm to detect and differentiate norA alleles, and found the association of norA alleles with specific S. aureus clonal lineages.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Infectious Diseases

Towards clinical breakpoints for non-tuberculous mycobacteria-Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution

Gabrielle Froberg, Florian P. Maurer, Erja Chryssanthou, Louise Fernstrom, Hanaa Benmansour, Samira Boarbi, Anne Torunn Mengshoel, Peter Michael Keller, Miguel Viveiros, Diana Machado, Margaret M. Fitzgibbon, Simone Mok, Jim Werngren, Daniela Maria Cirillo, Fernando Alcaide, Hanne-Leena Hyyrylainen, Alexandra Aubry, Sonke Andres, Darshaalini Nadarajan, Erik Svensson, John Turnidge, Christian G. Giske, Gunnar Kahlmeter, Emmanuelle Cambau, Jakko van Ingen, Thomas Schon

Summary: The study evaluated the minimum inhibitory concentration (MIC) distributions of non-tuberculous mycobacteria (NTM) to establish antimicrobial susceptibility testing (AST) breakpoints. MIC distributions for drugs against Mycobacterium avium complex (MAC) and Mycobacterium abscessus (MAB) were collected from 12 laboratories. Epidemiological cut-off values (ECOFFs) and tentative ECOFFs (TECOFFs) were determined, highlighting the need for further method refinement in establishing clinical breakpoints for NTM.

CLINICAL MICROBIOLOGY AND INFECTION (2023)

Article Agriculture, Dairy & Animal Science

Exploring Efflux as a Mechanism of Reduced Susceptibility towards Biocides and Fluoroquinolones in Staphylococcus pseudintermedius

Marta Leal, Catarina Morais, Barbara Ramos, Constanca Pomba, Patricia Abrantes, Sofia Santos Costa, Isabel Couto

Summary: This study aimed to evaluate the contribution of efflux to biocide and fluoroquinolone resistance in S. pseudintermedius. The results showed that efflux activity significantly increased resistance to biocides, which was strain-specific and glucose-dependent. Fluoroquinolone resistance was mainly related to target gene mutations. This study highlights the importance of efflux-mediated resistance in S. pseudintermedius and provides a methodological basis for further studies on this important veterinary pathogen.

ANIMALS (2023)

Editorial Material Public, Environmental & Occupational Health

Antimicrobial resistance, society and environment: A glocal syndemic

Paulo Ferrinho, Miguel Viveiros, Ines Fronteira

ONE HEALTH (2023)

Review Infectious Diseases

Lenacapavir: A novel injectable HIV-1 capsid inhibitor

Allison M. Hitchcock, Wesley D. Kufel, Keri A. Mastro Dwyer, Eric F. Sidman

Summary: Lenacapavir is a novel HIV-1 treatment option for patients with multidrug-resistant (MDR) HIV-1 infection. It has a favorable pharmacokinetic profile and has shown good tolerability and efficacy in clinical trials.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2024)

Article Infectious Diseases

Characterization and outcomes of difficult-to-treat patients starting modern first-line ART regimens: Data from the ICONA cohort

Roberta Gagliardini, Alessandro Tavelli, Stefano Rusconi, Sergio Lo Caputo, Vincenzo Spagnuolo, Maria Mercedes Santoro, Andrea Costantini, Alessandra Vergori, Franco Maggiolo, Andrea Giacomelli, Giulia Burastero, Giordano Madeddu, Eugenia Quiros Roldan, Antonella d'Arminio Monforte, Andrea Antinori, Alessandro Cozzi-Lepri

Summary: This study evaluated multiple treatment failures to modern antiretroviral therapy in HIV-infected individuals and found that approximately 4% of them were difficult to treat. The difficult to treat group, compared to the non-difficult to treat group, was characterized by older age, higher prevalence of AIDS, lower CD4+ cell count, and higher risk of treatment failure.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2024)